LyophilisedRET-30
Retatrutide
30mg≥99.5% Purity
Retatrutide 30mg lyophilised powder for advanced clinical protocols.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors.
Read the researchClinical Benefits
- Triple receptor agonist mechanism
- Higher dosage for advanced protocols
- Pharmaceutical-grade purity standards
- Lyophilised for extended stability
Specifications
MechanismTriple agonist (GIP/GLP-1/Glucagon)
Purity≥99.5%
Dosage30mg per vial
Storage & Handling
- Store at 2–8°C
- Protect from light
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.